A preview of this full-text is provided by American Society for Microbiology.
Content available from Journal of Clinical Microbiology
This content is subject to copyright. Terms and conditions apply.
JOURNAL OF CLINICAL MICROBIOLOGY, July 2008, p. 2393–2395 Vol. 46, No. 7
0095-1137/08/$08.00⫹0 doi:10.1128/JCM.00740-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
Microbiological Characteristics, Presumptive Identification, and
Antibiotic Susceptibilities of Staphylococcus lugdunensis
䌤
Thean Yen Tan,
1
* Siew Yong Ng,
1
and Jie He
2
Division of Laboratory Medicine, Changi General Hospital, Singapore,
1
and Department of Pathology,
Singapore General Hospital, Singapore
2
Received 17 April 2008/Accepted 5 May 2008
This study validated abbreviated methods for the presumptive identification of Staphylococcus lugdunensis
and studied the antibiotic susceptibilities of 106 isolates. The combination of positive responses to ornithine
and pyrrolidonyl arylamidase identified all S. lugdunensis isolates. Resistance to penicillin and methicillin was
detected in 27 and 5% of isolates, respectively.
Staphylococcus lugdunensis, a coagulase-negative staphylo-
coccus, has clinical characteristics that resemble those of the
coagulase-positive Staphylococcus aureus. Infections attributed
to S. lugdunensis include infective endocarditis (19), bactere-
mia, meningitis (6), bone and joint infections (7), and soft-
tissue infections (16). S. lugdunensis generally is susceptible to
anti-staphylococcal antibiotics (18), but increasing penicillin
resistance has been reported (9, 13). Meanwhile, oxacillin sus-
ceptibility breakpoints for S. lugdunensis were changed in 2005
(3), and oxacillin disc breakpoints were revised in 2005 and
subsequently replaced by cefoxitin disc breakpoints in 2006 (2).
The current reference method for the identification of coagu-
lase-negative staphylococci (1) is labor-intensive. Screening for
S. lugdunensis by detecting clumping factor (15, 21) or using a
limited number of biochemical tests (5, 12, 15) has been pro-
posed, but these methods have been evaluated only against
small numbers of S. lugdunensis isolates.
The aims of this study were to evaluate the use of simple
screening strategies for the identification of S. lugdunensis,to
comprehensively describe the microbiological characteristics
of S. lugdunensis, and to evaluate the antibiotic susceptibility of
clinical isolates.
The accuracy of three abbreviated identification protocols
and two commercial identification kits (ID 32 Staph and Vitek
ID-GP; both from bioMe´rieux, France) was evaluated against
a collection of coagulase-negative staphylococci that were iso-
lated from clinical samples. Isolates from the collection were
identified using a panel of 30 phenotypic and biochemical tests
(1) and included Staphylococcus capitis (n ⫽7), Staphylococcus
caprae (n⫽5), Staphylococcus cohnii (n⫽2), Staphylococcus
epidermidis (n⫽14), Staphylococcus haemolyticus (n⫽24),
Staphylococcus hominis (n⫽3), Staphylococcus lugdunensis
(n⫽46), Staphylococcus saprophyticus (n⫽2), and Staphylo-
coccus warneri (n⫽3). The identification of 10 isolates (be-
longing to S. haemolyticus,S. cohnii,S. epidermidis, and S.
lugdunensis) was further confirmed by sequencing a 457-bp
sequence of the 16S rRNA gene (8). For the three abbreviated
identification protocols, isolates were tested for the presence
of pyrrolidonyl arylamidase (PYR) (Oxoid, United Kingdom),
ornithine decarboxylase (BioMedia, Malaysia), and urease
(BioMedia, Malaysia); trehalose utilization; alkaline phos-
phatase activity; and mannose utilization (the last three sub-
stances were from Rosco, Denmark). In the first identification
protocol, isolates that were positive for both PYR and orni-
thine decarboxylase were identified as S. lugdunensis.Inthe
second identification protocol, isolates that were positive for
PYR, ornithine decarboxylase, and mannose utilization were
identified as S. lugdunensis. The third identification protocol
identified an isolate as S. lugdunensis if it was positive for
trehalose and ornithine decarboxylase and negative for alka-
line phosphatase (12). The first and second identification pro-
tocols correctly identified all 46 isolates of S. lugdunensis (sen-
sitivity, 100%), while the third testing protocol identified 42
isolates of S. lugdunensis (sensitivity, 91%). None of the other
staphylococcal species was misidentified as S. lugdunensis by
the three protocols (specificity, 100%). ID 32 Staph correctly
identified 45 (98%) isolates of S. lugdunensis, and Vitek ID-GP
correctly identified 43 (93%) isolates of S. lugdunensis.
The 46 strains of S. lugdunensis were subcultured onto tryp-
ticase-soy agar plates with 5% sheep blood and incubated in
ambient atmosphere at 35°C for 3 days. Colonial morphology
was observed after 24, 48, and 72 h of incubation. Colonies
were 1 mm in diameter after 24 h of incubation and increased
to 3 mm after 48 h at 35°C. Forty (87%) isolates showed a
narrow border of beta-hemolysis after 24 h of incubation. After
48 h of incubation, 39 (85%) isolates showed significant beta-
hemolytic activity, and 4 isolates (9%) showed slight beta-
hemolysis. Colonies at 24 h typically were opaque white, with a
glossy sheen (n⫽40; 87%). At 48 and 72 h, 13 isolates (28%)
developed a yellow-white hue resembling that of S. aureus.S.
lugdunensis isolates had a characteristic sweet, hay-like odor
resembling that of the screwpine leaf, and this was prominent
in 38 (79%) isolates after 48 h of incubation.
The detection of clumping factor/protein A using three com-
mercial latex agglutination kits, Pastorex Staph (Bio-Rad,
France), Staphaurex, and BactiStaph (both from Remel,
United States), was performed on overnight cultures. Rapid
and clear agglutination was classified as a positive result, while
slower and less distinct agglutination was classified as a weak
* Corresponding author. Mailing address: Division of Laboratory
Medicine, Changi General Hospital, 2 Simei Street 3, Singapore,
529889. Phone: 65-68504934. Fax: 65-64269507. E-mail: thean_yen_tan
@cgh.com.sg.
䌤
Published ahead of print on 14 May 2008.
2393
positive result. The interpretation of a positive agglutination
test was always made with reference to the manufacturer’s
instructions. All isolates were tested for the presence of free
coagulase using a rabbit plasma tube coagulase test method.
The three latex agglutination kits showed different perfor-
mance characteristics. BactiStaph and Pastorex Staph showed
strongly positive agglutination for 49 and 42% of S. lugdunensis
isolates, respectively, while strongly positive agglutination was
present in only 9% of isolates that were tested by Staphaurex.
For both positive and weak-positive agglutination reactions,
the test kit positivity was 73, 76, and 17% for BactiStaph,
Pastorex Staph, and Staphaurex, respectively. All isolates were
negative for free coagulase.
Antibiotic susceptibility testing was performed on a separate
collection of 106 isolates of S. lugdunensis that were collected
prospectively from clinical specimens from 2004 to 2006 and
identified using the first identification protocol. Antibiotic sus-
ceptibilities were performed by disk diffusion and were inter-
preted using CLSI guidelines (4), except for oxacillin, for which
the last applicable guidelines from 2005 were applied (3).
MICs of penicillin and oxacillin were determined by agar di-
lution. All isolates were screened for the mecA gene (20), and
mecA-positive isolates were tested for the presence of pbp2⬘by
latex agglutination (Oxoid, United Kingdom) using previously
described methods (10). The species identification of all mecA-
positive S. lugdunensis isolates was confirmed by 16S rRNA
gene sequencing. The antibiotic susceptibilities of 106 clinical
isolates are listed in Table 1. Twenty-nine isolates (27%) were
resistant to penicillin by agar dilution. The modal oxacillin
MIC was 1 g/ml (Table 2), which is higher than those for most
other staphylococcal species but similar to that for S. sapro-
phyticus and S. cohnii (11, 13). The oxacillin MICs for five
isolates were ⱖ4g/ml, and all were positive for both mecA
and pbp2⬘. Current cefoxitin disk breakpoints accurately de-
tected mecA-positive isolates, as opposed to oxacillin disk
breakpoints (susceptibility breakpoint, ⱕ13 mm; resistance
breakpoint, ⱖ10 mm), which had poor sensitivity (80%) and
specificity (65%).
This study comprehensively examined the use of abbreviated
protocols for the presumptive identification of S. lugdunensis.
Our results show that the use of clumping factor may not be a
reliable screening method to identify this organism, as results
appear to be kit dependent. The two-test protocol that utilized
ornithine decarboxylase and PYR accurately identified all of
our S. lugdunensis strains. The suggested addition of mannose
utilization to differentiate S. haemolyticus from S. lugdunensis
(15) was not required to improve the specificity of this proto-
col. Of the commercial kits, the ID 32 Staph kit performed
marginally better than the Vitek ID-GP card.
S. lugdunensis generally has been characterized as being
susceptible in vitro to most antibiotics. Early studies reported
penicillin resistance rates of ⬍4% (14), while more recent
studies report penicillin resistance rates of 12 to 15% (9, 13).
Only one methicillin-resistant isolate has been reported (17).
Over a quarter of clinical isolates of S. lugdunensis in our
population were resistant to penicillin, while methicillin resis-
tance was present in 5% of study isolates. However, other than
that for tetracycline, resistance to non-beta-lactam antibiotics
was low. Current CLSI breakpoints for oxacillin MIC and
cefoxitin disc testing clearly differentiate mecA-positive strains
of S. lugdunensis. The latex detection of pbp2 also is a viable
alternative.
This study validates a simple screening strategy to differen-
tiate S. lugdunensis from other coagulase-negative staphylo-
cocci. This will improve the recognition of clinical disease and
the surveillance of antibiotic resistance in S. lugdunensis.
This study was funded by a grant from the National Medical Re-
search Council.
REFERENCES
1. Bannerman, T. L. 2003. Staphylococcus,Micrococcus, and other catalase-
positive cocci that grow aerobically, p. 384–404. In P. R. Murray, E. J. Baron,
J. H. Jorgenson, M. A. Pfaller, and R. H. Yolken (eds.), Manual of clinical
microbiology, 8th ed., vol. 1. American Society for Microbiology, Washing-
ton, DC.
2. Clinical Laboratory Standards Institute. 2006. Performance standards for
antimicrobial disk susceptibility tests; approved standard. M2–A9. Clinical
Laboratory Standards Institute, Wayne, PA.
3. Clinical Laboratory Standards Institute. 2005. Performance standards for
antimicrobial susceptibility testing; 15th informational supplement. NCCLS/
CLSI M100–S15. Clinical Laboratory Standards Institute, Wayne, PA.
4. Clinical Laboratory Standards Institute. 2007. Performance standards for
antimicrobial susceptibility testing; 16th informational supplement. M100–
S17. Clinical Laboratory Standards Institute, Wayne, PA.
5. De Paulis, A. N., S. C. Predari, C. D. Chazarreta, and J. E. Santoianni. 2003.
Five-test simple scheme for species-level identification of clinically signifi-
cant coagulase-negative staphylococci. J. Clin. Microbiol. 41:1219–1224.
6. Ebright, J. R., N. Penugonda, and W. Brown. 2004. Clinical experience with
Staphylococcus lugdunensis bacteremia: a retrospective analysis. Diagn. Mi-
crobiol. Infect. Dis. 48:17–21.
7. Greig, J. M., and M. J. Wood. 2003. Staphylococcus lugdunensis vertebral
osteomyelitis. Clin. Microbiol. Infect. 9:1139–1141.
8. Harmsen, D., C. Singer, J. Rothganger, T. Tonjum, G. S. de Hoog, H. Shah,
J. Albert, and M. Frosch. 2001. Diagnostics of Neisseriaceae and Moraxel-
laceae by ribosomal DNA sequencing: ribosomal differentiation of medical
microorganisms. J. Clin. Microbiol. 39:936–942.
9. Hellbacher, C., E. Tornqvist, and B. Soderquist. 2006. Staphylococcus lug-
dunensis: clinical spectrum, antibiotic susceptibility, and phenotypic and ge-
notypic patterns of 39 isolates. Clin. Microbiol. Infect. 12:43–49.
10. Hussain, Z., L. Stoakes, S. Garrow, S. Longo, V. Fitzgerald, and R. Lanni-
gan. 2000. Rapid detection of mecA-positive and mecA-negative coagulase-
negative staphylococci by an anti-penicillin binding protein 2a slide latex
agglutination test. J. Clin. Microbiol. 38:2051–2054.
11. Hussain, Z., L. Stoakes, V. Massey, D. Diagre, V. Fitzgerald, S. El Sayed, and
TABLE 1. Antibiotic susceptibilities of S. lugdunensis strains based
on disc susceptibility testing
a
Antibiotic No. of isolates
tested
No. (%)
sensitive
No. (%)
resistant
Cefoxitin 106 101 (95.3) 5 (4.7)
Ciprofloxacin 106 105 (99.1) 1 (0.9)
Clindamycin 106 104 (98.2) 2 (1.8)
Cotrimoxazole 106 106 (100)
Erythromycin 106 104 (98.2) 2 (1.8)
Penicillin 106 77 (72.6) 29 (27.4)
Tetracycline 106 94 (88.7) 12 (11.3)
a
The interpretative criteria are from reference 4.
TABLE 2. No. of strains positive or negative for the mecA gene
according to oxacillin MICs
a
mecA status No. of strains with oxacillin MIC (g/ml) of:
0.125 0.25 0.5 0.75 1 2 16 ⱖ32
Negative 2 13 53 2 29 2
Positive 4 1
a
Methicillin resistance is defined as an oxacillin MIC of ⱖ4g/ml.
2394 NOTES J. CLIN.MICROBIOL.
R. Lannigan. 2000. Correlation of oxacillin MIC with mecA gene carriage in
coagulase-negative staphylococci. J. Clin. Microbiol. 38:752–754.
12. Ieven, M., J. Verhoeven, S. R. Pattyn, and H. Goossens. 1995. Rapid and
economical method for species identification of clinically significant coagu-
lase-negative staphylococci. J. Clin. Microbiol. 33:1060–1063.
13. Mateo, M., J. R. Maestre, L. Aguilar, F. Cafini, P. Puente, P. Sanchez, L. Alou,
M. J. Gimenez, and J. Prieto. 2005. Genotypic versus phenotypic characteriza-
tion, with respect to susceptibility and identification, of 17 clinical isolates of
Staphylococcus lugdunensis. J. Antimicrob. Chemother. 56:287–291.
14. Paterson, D. L., and N. Nuttall. 1997. Serious infections due to Staphylo-
coccus lugdunensis. Aust. N. Z. J. Med. 27:591.
15. Schnitzler, N., R. Meilicke, G. Conrads, D. Frank, and G. Haase. 1998.
Staphylococcus lugdunensis: report of a case of peritonitis and an easy-to-
perform screening strategy. J. Clin. Microbiol. 36:812–813.
16. Tan, T. Y., S. Y. Ng, and W. X. Ng. 2006. Clinical significance of coagulase-
negative staphylococci recovered from nonsterile sites. J. Clin. Microbiol.
44:3413–3414.
17. Tee, W. S., S. Y. Soh, R. Lin, and L. H. Loo. 2003. Staphylococcus lugdunensis
carrying the mecA gene causes catheter-associated bloodstream infection in
premature neonate. J. Clin. Microbiol. 41:519–520.
18. van der Mee-Marquet, N., A. Achard, L. Mereghetti, A. Danton, M. Minier,
and R. Quentin. 2003. Staphylococcus lugdunensis infections: high frequency
of inguinal area carriage. J. Clin. Microbiol. 41:1404–1409.
19. Van Hoovels, L., P. De Munter, J. Colaert, I. Surmont, E. Van Wijngaerden,
W. E. Peetermans, and J. Verhaegen. 2005. Three cases of destructive native
valve endocarditis caused by Staphylococcus lugdunensis. Eur. J. Clin. Micro-
biol. Infect. Dis. 24:149–152.
20. Vannuffel, P., J. Gigi, H. Ezzedine, B. Vandercam, M. Delmee, G. Wauters,
and J. L. Gala. 1995. Specific detection of methicillin-resistant Staphylococ-
cus species by multiplex PCR. J. Clin. Microbiol. 33:2864–2867.
21. Zbinden, R., F. Muller, F. Brun, and A. von Graevenitz. 1997. Detection of
clumping factor-positive Staphylococcus lugdunensis by Staphaurex Plus. J.
Microbiol. Methods 31:95–98.
VOL. 46, 2008 NOTES 2395
Content uploaded by Thean Yen Tan
Author content
All content in this area was uploaded by Thean Yen Tan
Content may be subject to copyright.